Prof. Agdo. Dr. Leandro Ricagniadmin2026-10-28T20:56:48-03:00 Prof. Agdo. Dr. Leandro RicagniDoctor, ProfesorOncólogo Radioterapeuta Profesor Agregado de la Unidad Académica de Radioterapia, Facultad de Medicina, Universidad de la República. Temas Conferencia 2026 Tratamientos no invasivos del cáncer de próstata a través de la radioterapia Lectura adicional recomendadaadmin2026-10-28T21:18:36-03:00Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer — ProtecTadmin2026-10-28T21:15:08-03:00Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trialadmin2026-10-28T21:10:50-03:00Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocoladmin2026-10-28T21:05:39-03:00High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trialadmin2026-10-28T20:47:40-03:00Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer — PACE-B
admin2026-10-28T21:18:36-03:00Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer — ProtecT
admin2026-10-28T21:15:08-03:00Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial
admin2026-10-28T21:10:50-03:00Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
admin2026-10-28T21:05:39-03:00High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial
admin2026-10-28T20:47:40-03:00Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer — PACE-B
